806 research outputs found

    Bright Flash Neutron Radiography at the McClellan Nuclear Research Reactor

    Get PDF
    AbstractThe University of California, Davis McClellan Nuclear Research Center (MNRC) operates a 2 MW TRIGATM reactor, which is currently the highest power TRIGATM reactor in the United States. The Center was originally build by the US Air Force to detect hidden defects in aircraft structures using neutron radiography; the Center can accommodate samples as large as 10.00 m long, 3.65 m high, and weighing up to 2,270kg.The MNRC reactor can be pulsed to 350 MW for about 30ms (FWHM). The combination of a short neutron pulse with a fast microchannel plate based neutron detector enables high-resolution flash neutron radiography to complement conventional neutron radiograph

    Maximum-likelihood absorption tomography

    Full text link
    Maximum-likelihood methods are applied to the problem of absorption tomography. The reconstruction is done with the help of an iterative algorithm. We show how the statistics of the illuminating beam can be incorporated into the reconstruction. The proposed reconstruction method can be considered as a useful alternative in the extreme cases where the standard ill-posed direct-inversion methods fail.Comment: 7 pages, 5 figure

    Eruptive shearing of tube pumice: pure and simple

    Get PDF
    Abstract. Understanding the physico-chemical conditions extant and mechanisms operative during explosive volcanism is essential for reliable forecasting and mitigation of volcanic events. Rhyolitic pumices reflect highly vesiculated magma whose bubbles can serve as a strain indicator for inferring the state of stress operative immediately prior to eruptive fragmentation. Obtaining the full kinematic picture reflected in bubble population geometry has been extremely difficult, involving dissection of a small number of delicate samples. The advent of reliable high-resolution tomography has changed this situation radically. Here we demonstrate via the use of tomography how a statistically powerful picture of the shapes and connectivity of thousands of individual bubbles within a single sample of tube pumice emerges. The strain record of tube pumice is dominated by simple shear (not pure shear) in the late deformational history of vesicular magma before eruption. This constraint in turn implies that magma ascent is conditioned by a velocity gradient at the point of origin of tube pumice. Magma ascent accompanied by simple shear should enhance high eruption rates inferred independently for these highly viscous systems. </jats:p

    First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease

    Get PDF
    BackgroundA novel self-expanding drug-eluting stent was designed to slowly release everolimus to prevent restenosis following peripheral arterial intervention. The purpose of the first-in-human Superficial Femoral Artery Treatment with Drug-Eluting Stents (STRIDES) trial was to evaluate the safety and efficacy of this device for the treatment of symptomatic superficial femoral and proximal popliteal arterial occlusive disease.Methods and ResultsOne hundred four patients were enrolled at 11 European investigative centers in a prospective, nonrandomized, single-arm trial. The patients had severe symptomatic vascular disease, including a significant proportion of patients with critical limb ischemia (17%), diabetes (39%), and single-vessel outflow (26%). The mean lesion length was 9.0 ± 4.3 cm. Ninety-nine percent of patients were available for 12-month follow-up, including duplex imaging in 90% and arteriography in 83%. Clinical improvement, defined as a sustained decrease in Rutherford-Becker clinical category, was achieved in 80% of patients. Primary patency (freedom from ≥50% in-stent restenosis) was 94 ± 2.3% and 68 ± 4.6% at 6 and 12 months, respectively. Plain radiographic examination of 122 implanted devices at 12 months revealed no evidence for stent fracture.ConclusionsThe everolimus-eluting self-expanding nitinol stent can be successfully implanted in patients with severe peripheral arterial disease with favorable outcomes and clinical improvements observed in the majority of patients
    corecore